CDTX(Delisted)
Cidara Therapeutics·NASDAQ
--
--(--)
Stock Fundamental
0.00 / 10Overall Score
—Investment Rating
0.00 / 10Overall Score
—Investment Rating
RiskExcellent
Valuation0.0/10
Key Valuation Metric
--P/E Ratio
Market Cap--
Earnings--
Historical Price to Earnings Ratio
Share Price vs Future Cash Flow Value
No data available
Future Growth0.0/10
Earnings and Revenue Growth Forecasts
No forecast data
Future Return on Equity
No ROE forecast
Past Performance0.0/10
Revenue & Expenses Breakdown
No revenue breakdown
Earnings & Revenue
No earnings data
Free Cash Flow vs Earnings Analysis
No FCF bridge data
Financial Health0.0/10
Debt to Equity History and Analysis
No financial health series
Balance Sheet
No balance sheet snapshot
Dividends0.0/10
Stability and Growth of Payments
No dividend stability data
Dividend Yield vs Market
No dividend yield vs market data
Earnings Payout to Shareholders
No earnings payout data
Cash Payout to Shareholders
No cash payout data
Is CDTX a Buy, Sell, or Hold?
- Based on a composite score of 6.16/10, we rate CDTX as a Outperform. Our analysis breaks down into 5.47/10 for Fundamentals, 6.21/10 for Technicals, and 6.47/10 for Sentiment, indicating the stock is likely to See further upside.
What is the current technical signals for CDTX?
Is CDTX fundamentally strong?
What is the analyst consensus for CDTX?
Is CDTX a Buy, Sell, or Hold?
- Based on a composite score of 6.16/10, we rate CDTX as a Outperform. Our analysis breaks down into 5.47/10 for Fundamentals, 6.21/10 for Technicals, and 6.47/10 for Sentiment, indicating the stock is likely to See further upside.
Is CDTX fundamentally strong?
What is the current technical signals for CDTX?
What is the analyst consensus for CDTX?
